| ||
China Nuokang Bio-Pharmaceutical Inc. Adjourns Extraordinary General ... NASDAQ 15, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it has adjourned its extraordinary general meeting of shareholders that was called to authorize and approve the ... See all stories on this topic » | ||
Velocity Pharmaceutical Development Announces Clinical Development ... The Herald | HeraldOnline.com 15, 2013 — /PRNewswire/ -- Velocity Pharmaceutical Development LLC (VPD) today announced the signing of a Licensing Agreement to pursue a drug development program utilizing EuMederis Pharmaceuticals' EuPort™ technology for optimizing the ... See all stories on this topic » | ||
Genpact Signs Five-Year Contract Extension With Major Pharmaceutical ... Daily Markets (press release) 15, 2013 /PRNewswire/ – Genpact Limited (NYSE:G), a global leader in business process management and technology services, today announced it has been awarded a five-year contract extension by global pharmaceutical leader GlaxoSmithKline (GSK) ... See all stories on this topic » | ||
Ace and XL sued by pharmaceutical giant Royal Gazette The case is AstraZeneca Insurance Company (the pharmaceutical giant's captive insurance company) versus XL Insurance (Bermuda) and Ace Bermuda Insurance. The dispute is over whether the two Bermuda-based reinsurers can be held liable for ... See all stories on this topic » | ||
No break in sight for pharmaceutical monopoly The Copenhagen Post Following an intense lobbying effort by the nation's chemists, it appears likely that parliament will allow them to retain their centuries-old monopoly on selling prescription medicines. Although no formal decision has been reached, the mood among MPs ... See all stories on this topic » | ||
Medical research to underpin Finland's future growth The Pharma Letter Medical research - and pharmaceutical research as its integral part - can constitute an important footing for Finland's future growth, according to Jussi Merikallio, general manager of trade group Pharma Industry Finland (PIF), noting that a recent PIF ... See all stories on this topic » | ||
Cutting Edge Information Finds Top-Performing Pharmaceutical Companies ... Genetic Engineering News (press release) A Cutting Edge Information study found that 80% of surveyed diagnostic companies begin biomarker development by the time a compound enters the animal testing phase. In their effort to replace blockbuster drugs whose patent protection is quickly running ... See all stories on this topic » | ||
|
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment